Plasma proteome profiling discovers novel proteins associated with non‐alcoholic fatty liver disease
- Sprache
-
Englisch
- Identifier
-
1244757144
Beteiligte Personen und Organisationen
Niu, Lili
Geyer, Philipp E.
Wewer Albrechtsen, Nicolai J.
Gluud, Lise L.
Santos, Alberto
Doll, Sophia
Treit, Peter V.
Holst, Jens J.
Knop, Filip K.
Vilsbøll, Tina
Junker, Anders
Sachs, Stephan
Stemmer, Kerstin
Müller, Timo D.
Tschöp, Matthias H.
Hofmann, Susanna M.
Mann, Matthias
Geyer, Philipp E.
Wewer Albrechtsen, Nicolai J.
Gluud, Lise L.
Santos, Alberto
Doll, Sophia
Treit, Peter V.
Holst, Jens J.
Knop, Filip K.
Vilsbøll, Tina
Junker, Anders
Sachs, Stephan
Stemmer, Kerstin
Müller, Timo D.
Tschöp, Matthias H.
Hofmann, Susanna M.
Mann, Matthias
- DOI
-
10.15252/msb.20188793
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
26.01.2023, 13:54 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Niu, Lili
- Geyer, Philipp E.
- Wewer Albrechtsen, Nicolai J.
- Gluud, Lise L.
- Santos, Alberto
- Doll, Sophia
- Treit, Peter V.
- Holst, Jens J.
- Knop, Filip K.
- Vilsbøll, Tina
- Junker, Anders
- Sachs, Stephan
- Stemmer, Kerstin
- Müller, Timo D.
- Tschöp, Matthias H.
- Hofmann, Susanna M.
- Mann, Matthias
Ähnliche Objekte (12)
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Murine one-carbon metabolism in non-alcoholic fatty liver disease
Murine one-carbon metabolism in non-alcoholic fatty liver disease
Assessment of Alcohol Consumption in Outpatients with Non-alcoholic Fatty Liver Disease
Impact of heterofermentative lactobacilli on development of non-alcoholic fatty liver disease
Enhanced expression of BMP6 inhibits hepatic fibrosis in non-alcoholic fatty liver disease
The NAD salvage pathway during the progression of non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease and psoriasis - is there a shared proinflammatory network?
The NAD salvage pathway during the progression of non-alcoholic fatty liver disease
NFATc1 driven ER-stress responses in the progression of non-alcoholic fatty liver disease
Phenotyping non‐alcoholic fatty liver disease by the gut microbiota: ready for prime time?
Why bile acids are so important in non-alcoholic fatty liver disease (NAFLD) progression
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Murine one-carbon metabolism in non-alcoholic fatty liver disease
Murine one-carbon metabolism in non-alcoholic fatty liver disease
Assessment of Alcohol Consumption in Outpatients with Non-alcoholic Fatty Liver Disease
Impact of heterofermentative lactobacilli on development of non-alcoholic fatty liver disease
Enhanced expression of BMP6 inhibits hepatic fibrosis in non-alcoholic fatty liver disease
The NAD salvage pathway during the progression of non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease and psoriasis - is there a shared proinflammatory network?
The NAD salvage pathway during the progression of non-alcoholic fatty liver disease
NFATc1 driven ER-stress responses in the progression of non-alcoholic fatty liver disease
Phenotyping non‐alcoholic fatty liver disease by the gut microbiota: ready for prime time?
Why bile acids are so important in non-alcoholic fatty liver disease (NAFLD) progression
Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis : mechanisms, treatment and prevention
Murine one-carbon metabolism in non-alcoholic fatty liver disease
Murine one-carbon metabolism in non-alcoholic fatty liver disease
Assessment of Alcohol Consumption in Outpatients with Non-alcoholic Fatty Liver Disease
Impact of heterofermentative lactobacilli on development of non-alcoholic fatty liver disease
Enhanced expression of BMP6 inhibits hepatic fibrosis in non-alcoholic fatty liver disease
The NAD salvage pathway during the progression of non-alcoholic fatty liver disease
Non-alcoholic fatty liver disease and psoriasis - is there a shared proinflammatory network?
The NAD salvage pathway during the progression of non-alcoholic fatty liver disease
NFATc1 driven ER-stress responses in the progression of non-alcoholic fatty liver disease
Phenotyping non‐alcoholic fatty liver disease by the gut microbiota: ready for prime time?